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SUMMARY. The objective of the present investigation was to investigate the effects of selected drugs (cap-
topril and celecoxib) properties on different parameters drug entrapment, in vitro drug release, release
pattern, in vitro drug permeation and buoyancy in the formulation of Eudragit S100 non effervescent
floating microparticulates. Microparticulates were in size ranges 268.36-352.27 μm (captopril) and 271.36-
365.54 μm (celecoxib). Encapsulation efficiency of celecoxib was good as compare to captopril. In vitro
permeation studies showed in range (ES6) 74.83 μg – (ES1) 79.84 μg (celecoxib), (EU6) 57.01 μg - (EU1)
67.38 μg (captopril). In vitro release followed Non-Fickian diffusion mechanism while in vitro permeation
kinetics revealed the super case II transport mechanism. Taken together, water insoluble (celecoxib) drug
showed suitable combination with Eudragit S100. This study concluded that the effect of various parame-
ter on the characteristics of Eudragit gastroretentive drug delivery system by non effervescent technique
using celecoxib and captopril having different physicochemical characterization. 
